COVID-19 primary prevention
COVID-19 Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
COVID-19 primary prevention On the Web |
American Roentgen Ray Society Images of COVID-19 primary prevention |
Risk calculators and risk factors for COVID-19 primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Carla Vorsatz, M.D.[2]
Overview
Primary Prevention
According to a modeling study [1]: "Implementing the combined intervention of
- quarantining infected individuals and their family members,
- workplace distancing, and
- school closure once community transmission has been detected
...could substantially reduce the number of SARS-CoV-2 infections."
Similar findings have been modeled by the Medical Research Council (MRC) Centre for Global Infectious Disease Analysis and WHO Collaborating Centre for Infectious Disease Modelling [2].
References
- ↑ Koo, Joel R; Cook, Alex R; Park, Minah; Sun, Yinxiaohe; Sun, Haoyang; Lim, Jue Tao; Tam, Clarence; Dickens, Borame L (2020). "Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study". The Lancet Infectious Diseases. doi:10.1016/S1473-3099(20)30162-6. ISSN 1473-3099.
- ↑ Ferguson, N.; Laydon, D.; Nedjati Gilani, G.; Imai, N.; Ainslie, K.; Baguelin, M.; Bhatia, S.; Boonyasiri, A.; Cucunuba Perez, Zulma; Cuomo-Dannenburg, G.; Dighe, A.; Dorigatti, I.; Fu, H.; Gaythorpe, K.; Green, W.; Hamlet, A.; Hinsley, W.; Okell, L.; Van Elsland, S.; Thompson, H.; Verity, R.; Volz, E.; Wang, H.; Wang, Y.; Walker, P.; Winskill, P.; Whittaker, C.; Donnelly, C.; Riley, S.; Ghani, A. (2020-03-16). Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Retrieved 2020-03-25.